EVALUASI INTERAKSI OBAT DALAM SATU LEMBAR RESEP DAN KELENGAPAN DAFTAR TILIK ALERGI OBAT PASIEN RAWAT JALAN RUMAH SAKIT X JAKARTA

Chusun Chusun; indrianti Poppy; Alam Nur Harun

doi:10.33759/jrki.v7i1.681

Authors

Chusun Chusun Akademi Farmasi Bhumi Husada Jakarta
indrianti Poppy Akademi Farmasi Bhumi Husada, Jakarta
Alam Nur Harun Instalasi Farmasi RS X Jakarta

DOI:

https://doi.org/10.33759/jrki.v7i1.681

Keywords:

Interaksi Obat dalam satu lembar resep, daftar tilik Alergi obat

Abstract

Clinical pharmacy services are direct services provided by pharmacists to patients in order to improve therapeutic outcomes and minimize the risk of side effects because the aim of using drugs is for patient safety. One of the clinical pharmacy services provided is assessment and prescription services which must be in accordance with clinical requirements, including the absence of drug interactions and patient allergy records. Based on clinical significance, the severity of drug interactions is classified into three, namely Major, Moderate and Minor. This research uses descriptive methods with retrospective data. The population in this study was all outpatient prescription sheets served from 1 October to 31 December 2023. Sampling used simple random sampling and determining the sample size using the Slovin formula so that the sample used was 460 prescription sheets. Identify drug interactions in one prescription sheet using the Drug Interaction Checker application (Drugbank.com). Results The research showed that of the 460 prescriptions examined, 301 prescriptions had the potential for drug interactions (65.4%), and 320 prescriptions (69.6%) completed the drug allergy checklist. The highest level of drug interactions was at moderate severity, namely 102 prescriptions (33.9%), and minor at 88 prescriptions (29.2%), and the lowest at major severity was 15 prescriptions (5%). If we look at the drug items in one prescription sheet, it can be concluded that there are 506 incidents with the highest level of severity at moderate level, namely 254 incidents (50.2%), which should be avoided in combination or only used in special circumstances and with close monitoring of health workers. While there were 219 minor interactions (43.3%); and major 33 events (6.5%), where this drug combination should not have been given.

Downloads

Download data is not yet available.

References

Agustin, O. A., & Fitrianingsih. (2020). Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis. e-SEHAD, 1(1), 1-10.

Bailie, G. R., Johnson, C. A., Mason, N. A., & Peter, W. L. (2004). Med Facts Pocket Guide of Drug Interactions (2nd ed.). Bone Care International.

Fima Perdani Rahayu & Yasmiwar Susilawati (2023). Identifikasi Interaksi Obat pada Resep tentang Gangguan Pernapasan di Bulan Februari 2023 di Apotek Kota Bandung. Jurnal Farmaka Volume 21 Nomor 3.

Indriani, L., & Oktaviani, E. (2019). Kajian Interaksi Obat Antihipertensi Pada Pasien Rawat Inap di Salah Satu Rumah Sakit di Bogor, Indonesia. Majalah Farmasetika, 212-219.

Kementerian Kesehatan, RI. (2017). Peraturan Menteri Kesehatan Republik Indonesia No.9 Tahun 2017 tentang Apotek.

Kementerian Kesehatan, RI. Peraturan Menteri Kesehatan Republik Indonesia No 72 Tahun 2016 tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Jakarta: Kementerian Kesehatan.

Mariyono, H. H., & Suryana, K. (2008). Adverse Drug Reaction. Jurnal Penyakit Dalam, 9, 164-172.

Rahmawati, E. (2022). Gambaran Interaksi Obat Azitromisin Pasien Covid-19 Komorbid Kardiovaskuler Di RS Panti Nirmala Malang. Malang: Karya Tulis Ilmiah.

Reyaan, I. B., Kuning, C., & Adyana, I. K. (2021). Studi Potensi Interaksi Obat Pada Resep Polifarmasi di Dua Apotek Kota Bandung. JMPF, 11(3), 145-152. doi:10.22146/jmpf.56931

Setiyowati, E. E. (2019). Profil Kejadian Alergi Obat Pada Pasien Rawat Inap di Rumah Sakit Muhammadiyah Lamongan. Universitas Muhammadiyah Gresik: Diploma Thesis.

Stockley, I. H. (2008). Stockley’s Drug Interactions (8th ed.). London: Pharmaceutical Press.

Undang-Undang, RI . No. 44 Tahun 2009 Tentang Rumah Sakit.

Agustin, O. A., & Fitrianingsih. (2020). Kajian interaksi obat berdasarkan kategori signifikansi klinis. e-SEHAD, 1(1), 1–10.

Bailie, G. R., Johnson, C. A., Mason, N. A., & Peter, W. L. (2004). Med Facts Pocket Guide of Drug Interactions (2nd ed.). Bone Care International.

Rahayu, F. P., & Susilawati, Y. (2023). Identifikasi interaksi obat pada resep tentang gangguan pernapasan di bulan Februari 2023 di Apotek Kota Bandung. Jurnal Farmaka, 21(3), 1–8.

Indriani, L., & Oktaviani, E. (2019). Kajian interaksi obat antihipertensi pada pasien rawat inap di salah satu rumah sakit di Bogor, Indonesia. Majalah Farmasetika, 4(3), 212–219.

Kementerian Kesehatan RI. (2016). Standar pelayanan kefarmasian di rumah sakit (Peraturan Menteri Kesehatan No. 72 Tahun 2016). Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan RI. (2017). Peraturan Menteri Kesehatan No. 9 Tahun 2017 tentang Apotek. Jakarta: Kementerian Kesehatan RI.

Mariyono, H. H., & Suryana, K. (2008). Adverse drug reaction. Jurnal Penyakit Dalam, 9, 164–172.

Rahmawati, E. (2022). Gambaran interaksi obat azitromisin pasien COVID-19 komorbid kardiovaskuler di RS Panti Nirmala Malang. Karya Tulis Ilmiah. Malang: Universitas Muhammadiyah Malang.

Reyaan, I. B., Kuning, C., & Adyana, I. K. (2021). Studi potensi interaksi obat pada resep polifarmasi di dua apotek Kota Bandung. JMPF, 11(3), 145–152. https://doi.org/10.22146/jmpf.56931

Setiyowati, E. E. (2019). Profil kejadian alergi obat pada pasien rawat inap di Rumah Sakit Muhammadiyah Lamongan. Diploma Thesis. Gresik: Universitas Muhammadiyah Gresik